DRL

The Indian market closed in the red for the third consecutive day on Wednesday. The S&P BSE Sensex fell by nearly 400 points while the Nifty50 closed below 16,000 levels.…
Read More...

Friday’s move compliments data points on the indices. We also saw a blend of short covering as well as long built up so there were so many large cap names which looked more formidable…
Read More...

Foreign brokerage CLSA has downgraded to 'underperform' while Morgan Stanley has maintained its underweight stance on . On Dr Reddy's Labs (DRL), Morgan Stanley has an 'overweight'…
Read More...

NEW DELHI: Dr Reddy's Laboratories () is likely to report a 25 per cent year-on-year (YoY) rise in net profit at Rs 710 crore, as per an ET NOW poll of analysts. The drugmaker had…
Read More...